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Summary
 
Macrophages differentiated from circulating peripheral blood monocytes are essential for host im-
mune responses and have been implicated in the pathogenesis of rheumatoid arthritis and athero-
sclerosis. In contrast to monocytes, macrophages are resistant to Fas-induced cell death by an
unknown mechanism. FLICE (Fas-associated death domain–like interleukin 1
 
b
 
–converting en-
zyme)–inhibitory protein (Flip), a naturally occurring caspase-inhibitory protein that lacks the
critical cysteine domain necessary for catalytic activity, is a negative regulator of Fas-induced apop-
tosis. Here, we show that monocyte differentiation into macrophages was associated with upreg-
ulation of Flip and a decrease in Fas-mediated apoptosis. Overexpression of Flip protected mono-
cytes from Fas-mediated apoptosis, whereas acute Flip inhibition in macrophages induced
apoptosis. Addition of an antagonistic Fas ligand antibody to Flip antisense–treated macrophages
rescued cultures from apoptosis, demonstrating that endogenous Flip blocked Fas-induced cell
death. Thus, the expression of Flip in macrophages conferred resistance to Fas-mediated apopto-
sis, which may contribute to the development of inflammatory disease.
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M
 
acrophages regulate host immune responses, contrib-
ute to acute and chronic inflammation, and protect
against microbial infection and tumor formation (1). Before
differentiation, peripheral blood monocytes are highly
susceptible to Fas (CD95/Apo-1)–mediated apoptosis (2–5).
In contrast, differentiated macrophages are resistant to nu-
merous death stimuli, including death receptor ligation (5,
6), antineoplastic agents, and ionizing irradiation (7), sug-
gesting upregulation of survival factor(s). The accumulation
of activated macrophages in diseased tissues is involved in
the pathogenesis of conditions such as rheumatoid arthritis
(8) and atherosclerosis (9). The mechanism(s) responsible for
macrophage resistance to apoptosis and persistence in dis-
ease states is unknown. Mice lacking a functional Fas–Fas
ligand (FasL) death receptor pathway displayed increased
macrophage numbers and activity (10, 11), in addition to
developing autoimmune disease and enhanced lymphocyte
survival. Thus, regulation of the Fas–FasL pathway may
contribute to macrophage homeostasis.
Oligomerization of Fas induces the recruitment of Fas-
associated protein with death domain (FADD [12, 13]), Fas-
associated death domain–like IL-1
 
b
 
–converting enzyme
(FLICE)
 
1
 
-associated huge protein (FLASH [14]), and the
cysteine protease caspase 8 (FLICE/MACH [15, 16]) to the
death-inducing signaling complex (DISC). Aggregation of
procaspase 8 results in auto- or trans-processing, which cleaves
the inactive procaspase forming an active heterotetrameric
caspase 8 (17–20). Once active, caspase 8 is released into
the cytosol, inducing the proteolytic cascade of apoptosis
(21). Direct inhibition of Fas-mediated apoptosis may oc-
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Abbreviations used in this paper:
 
 EGFP, enhanced green fluorescent pro-
tein; ETOH, ethanol; FBS, fetal bovine serum; FLICE, Fas-associated
death domain–like IL-1
 
b
 
–converting enzyme; Flip, FLICE-inhibitory
protein; PI, propidium iodide; RT, reverse transcriptase; TdT, terminal
deoxynucleotidyl transferase; TUNEL, TdT dUTP nick end labeling;
zVAD.fmk, benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone. 
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cur through FLICE-inhibitory protein (Flip, also called
CASPER, CLARP, FLAME-1, I-FLICE, CASH, or MRIT),
a novel Fas pathway–inhibitory protein (22–28) which acts
as a dominant negative caspase 8 (24, 29). 
 
Flip
 
 expression
results in two gene products due to alternate splicing (24).
The larger, Flip
 
L
 
, possesses two death effector domains (DEDs)
and a caspase-like domain in which tyrosine is substituted
for the active cysteine residue necessary for enzymatic ac-
tivity (24). The smaller protein, Flip
 
S
 
, possesses two DEDs,
but no caspase-like domain, similar to viral Flips (24).
Thus, in cells refractory towards Fas-induced apoptosis,
Flip may confer protection from unwarranted cell death.
The regulation of monocyte survival under serum-
depleted conditions has been extensively investigated (2–5,
30–32). In vitro, the vast majority of monocytes cultured in
the absence of serum undergo marked, spontaneous apopto-
sis, which was reduced by GM-CSF (5), IL-
 
b
 
, LPS, TNF-
 
a
 
(2, 5, 30, 31), or M-CSF (32). Inhibition of Fas or FasL
protected serum-deprived monocytes from apoptosis (3–5),
indicating that monocytes may be deleted through the Fas–
FasL pathway. Nonetheless, even in the presence of serum,
monocytes undergo spontaneous apoptosis (5) and are sus-
ceptible to Fas-induced cell death (4, 5). These data indi-
cate that monocytes lack an apoptosis inhibitory factor of the
death receptor pathway, which may be upregulated during
monocyte to macrophage differentiation.
We examined the regulation of Fas-mediated apoptosis
by Flip during monocyte differentiation into macrophages.
Monocytes undergo spontaneous apoptosis in serum during
days 1 and 2 after isolation, as indicated by terminal deoxy-
nucleotidyl transferase (TdT) dUTP nick end labeling
(TUNEL) analysis and hypodiploid DNA content. Neu-
tralization of FasL or addition of the general caspase inhibi-
tor benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone
(zVAD.fmk) rescued serum-treated monocytes from apop-
tosis. Immunoblot analyses revealed undetectable Flip expres-
sion in monocytes, which was upregulated in macrophages.
Additionally, Flip mRNA was present in macrophages, but
not in monocytes, indicating that Flip was transcriptionally
regulated. Procaspases 8 and 3 were reduced in monocytes
compared with macrophages, suggesting that the procaspases
were converted to the active state during monocyte apop-
tosis. Overexpression of Flip
 
L
 
 and Flip
 
S
 
 expression plasmids
rescued U937 monocytic cells from Fas-mediated apopto-
sis. Acute inhibition of Flip mRNA by antisense oligonu-
cleotides induced macrophage apoptosis, which was pre-
vented by an antagonistic FasL antibody. These data indicate
that Fas and FasL on neighboring macrophages interacted
and that, under the conditions used, the apoptotic signal
was blocked by Flip. Thus, during differentiation in vitro,
Flip upregulation was responsible for inhibition of the Fas–
FasL pathway, permitting macrophage survival.
 
Materials and Methods
 
Cell Isolation and Culture.
 
Mononuclear cells were isolated
by Histopaque (Sigma Chemical Co.) gradient centrifugation.
Peripheral blood monocytes were then isolated from the mono-
nuclear cells by either Percoll (Sigma Chemical Co.) gradient
centrifugation (3, 7) or countercurrent centrifugal elutriation (Beck-
man-Coulter) (7, 33). All experiments were performed on mono-
cytes that were isolated both ways, except where noted. There
were no differences in the results due to the method of isolation.
Monocyte purity was 
 
.
 
90% as determined by morphology, CD14
staining, and nonspecific esterase staining. Monocytes were differ-
entiated in RPMI containing 20% heat-inactivated fetal bovine se-
rum (FBS) plus 1 
 
m
 
g/ml polymyxin B sulfate (Sigma Chemical
Co.) (4, 5) in 24-well plates (Costar) except when noted.
 
Transient Transfection.
 
For transient transfections, 3 
 
3 
 
10
 
6
 
 U937
cells were cultured in 100-mm plates, cotransfected for 4 h with 8, 6,
or 4 
 
m
 
g of test plasmids and with 2 
 
m
 
g of CMV–enhanced green flu-
orescent protein (EGFP) expression plasmid (Clontech), using the
FuGENE™ procedure (1:5 ratio of DNA/FuGENE™; Roche Bio-
chemicals). Empty vector was added to transfections to yield a total
of 10 
 
m
 
g of DNA per transfection. After transfection, cultures were
washed, incubated in 20% FBS/RPMI for 12 h, and treated with
hamster anti-Fas antibody (500 ng/ml, clone CH11; MBL) for an
additional 12 h. U937 cells were collected, and EGFP-expressing
cells were quantified by flow cytometry. Nonviable cells were ex-
cluded by propidium iodide (PI) incorporation.
 
TUNEL Labeling and Nuclear Condensation.
 
Histopaque/Percoll-
isolated monocytes were cultured on 60-mm plates containing
glass coverslips treated with acetic acid/ethanol (ETOH) (34, 35).
At the indicated time points, cultures were fixed in 4% neutral
buffered formalin for 5 min and subjected to two washes in PBS.
Individual coverslips were treated with 0.5% NP-40 for 5 min,
followed by two PBS washes. TdT enzyme and a cocktail con-
taining dUTP conjugated to a fluorescein (FITC) were added to
the coverslips according to the manufacturer’s specifications (In
Situ Death Detection kit; Roche Biochemicals). Nuclei were
counterstained with Hoechst 33258 (Sigma Chemical Co.), and
mounted for examination using mounting media for fluorescence
(Kirkegaard & Perry). Specimens were examined and photo-
graphed on a Zeiss microscope equipped with a phase–contrast and
epifluorescence optics. Pictures were recorded on Zeiss software.
 
Flow Cytometric Analysis of Monocytes and Macrophages.
 
At the
indicated time points, cultures were harvested in 0.02% EDTA
and fixed in 70% ETOH overnight (36–38). Cells were then
stained with PI (Roche Biochemicals) as described previously
(35). The subdiploid peak, immediately adjacent to the G0/G1
peak (2N), was determined by flow cytometry using an EpicsXL
flow cytometer (Beckman-Coulter) and system 2 software (see
Fig. 1 B). Objects with minimal light scatter were excluded since
they may represent debris and would have inappropriately en-
hanced our estimate of the subdiploid population (38). For
TUNEL analysis by flow cytometry, immediately isolated and
1-d monocytes were analyzed with the Apo-Direct™ apoptosis
assay, according to the manufacturer’s specifications (PharMingen).
In brief, cultures were fixed in 1% paraformaldehyde, permeabi-
lized in 70% ETOH for 1 h, and incubated with FITC-dUTP,
TdT, and reaction buffer for 1 h. Cells were then analyzed for
FITC-dUTP incorporation by flow cytometry.
Fas expression was determined in immediately isolated mono-
cytes and 7-d macrophages that were harvested in 0.02% EDTA,
blocked in 50% human serum for 1 h, and then incubated with
FITC-labeled anti-Fas antibody (clone UB2; Beckman-Coulter)
or with FITC-labeled isotype control (Becton Dickinson). As ad-
ditional negative controls, monocytes and macrophages were an-
alyzed with FITC-conjugated anti-CD3 or anti–TCR-
 
g
 
/
 
d
 
 anti-
bodies (Becton Dickinson) and the appropriate isotype control. 
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For surface FasL staining, monocytes or 7-d macrophages were
blocked in 50% human serum for 1 h. Cells were then incubated
in 33% human serum/33% goat serum with either rabbit anti-
FasL (clone C-20; Santa Cruz Biotechnology), hamster anti-FasL
(clone 4H9; Beckman-Coulter), or normal control IgG (Sigma
Chemical Co.). Cells were then incubated with FITC-labeled
goat anti–rabbit antibody (Kirkegaard & Perry) or rabbit anti–
hamster antibody (Pel-Freez Biologicals). Mitochondrial perme-
ability transition in macrophages after anti-Fas or TNF-
 
a
 
 addi-
tion was analyzed by Rh123 (0.1 
 
m
 
g/ml; Molecular Probes).
Rh123 was added to cultures for 30 min before analysis by flow
cytometry, and live cells were determined by PI exclusion. Flow
cytometry was conducted at the Robert H. Lurie Comprehen-
sive Cancer Center, Flow Cytometry Core Facility of the North-
western University Medical School.
 
Modulation of Monocyte/Macrophage Apoptosis.
 
Monocytes or
macrophages were incubated with either anti-FasL antibody
(clone C-20), anti-FasL antibody (clone 4H9), anti-Fas antibody
(clone CH11), control IgG (Dako), zVAD.fmk (Enzyme System
Products), or TNF-
 
a
 
 (R&D Systems) for 24 h. Cultures were
harvested in 0.02% EDTA and examined for apoptosis. To inhibit
Flip expression, phosphorothioate oligodeoxynucleotides were cre-
ated to include the Flip initiation codon (24; Flip antisense oli-
gonucleotide 5
 
9
 
-GACTTCAGCAGACATCCTAC-3
 
9
 
). Control
nonsense phosphorothioate oligodeoxynucleotides have been de-
scribed previously (39; 5
 
9
 
-TGGATCCGACATGTCAGA-3
 
9
 
).
FITC-conjugated oligonucleotides (10 or 20 
 
m
 
M) were added to
macrophages for 24 h. Cells were removed in 0.02% EDTA,
fixed in 70% ETOH, stained with PI, and analyzed by flow cy-
tometry. Parallel cultures were harvested for immunoblot analy-
sis. Additionally, oligonucleotides in combination with either
rabbit anti-FasL (clone C-20), hamster anti-FasL (clone 4H9), or
control IgG (Dako) were also added to 7-d macrophages for 24 h.
Cells were analyzed for DNA fragmentation by Cell Death
ELISA (see below).
 
Reverse Transcriptase PCR Analysis.
 
Peripheral blood mono-
cytes, isolated by Histopaque/Percoll gradient centrifugation,
were differentiated in 20% FBS/RPMI/1 
 
m
 
g/ml polymyxin B
and harvested for RNA preparation as described by Chomczynski
et al. (40). 1 
 
m
 
g of total RNA was incubated in reaction buffer
containing oligo(dT) primer, Moloney murine leukemia virus re-
verse transcriptase (RT), reaction buffer, and RNase inhibitor for
1 h at 42
 
8
 
C according to the manufacturer’s specifications (Clon-
tech). The reaction was stopped by incubation at 94
 
8
 
C for 5 min.
Primers specific for Flip were as follows: forward, 5
 
9
 
-GAT-
GTCTGCTGAAGTCATCCATCA-3
 
9
 
; reverse for Flip
 
L
 
, 5
 
9
 
-CAC-
TACGCCCAGCCTTTTGG-3
 
9
 
, and reverse for Flip
 
S
 
, 5
 
9
 
-AGT-
AGAGGCAGTTCCATG-3
 
9
 
. The reverse Flip
 
S
 
 primer is within
the 3
 
9
 
 untranslated region of Flip
 
S
 
, thus allowing for delineation
between Flip
 
L
 
 and Flip
 
S
 
. The PCR reaction was carried out with
5 U Taq polymerase (Perkin Elmer) in a total volume of 100 
 
m
 
l.
Amplification was performed for 28 cycles (30 s denaturing at
94
 
8
 
C, 45 s annealing at 50
 
8
 
C, and 90 s extension at 72
 
8
 
C) in a
thermal cycler. Control human 
 
b
 
-actin primers were used under
parallel conditions (Clontech). The 1,470-bp Flip
 
L
 
, 620-bp Flip
 
S
 
,
and 838-bp 
 
b
 
-actin amplified products were analyzed by 1.0%
agarose gel electrophoresis and visualized under UV illumination
after being stained with ethidium bromide.
 
Western Blot Analysis.
 
Whole-cell extracts were prepared from
peripheral blood monocytes and differentiated in 20% FBS/
RPMI/1 
 
m
 
g/ml polymyxin B. 25 or 50 
 
m
 
g of extract, as indi-
cated, was analyzed by SDS-PAGE on 12.5% polyacrylamide gels,
and transferred to Immobilon 
 
P
 
 (Millipore) by semidry blotting.
 
Filters were blocked for 1 h at room temperature in PBS/0.2%
Tween 20/5% nonfat dry milk. The filters were then incubated
with rabbit anti-Flip (41), which recognizes both Flip isoforms,
with rabbit anti-caspase 8 antibody (Chemicon) or mouse anti-
caspase 3 antibody (Transduction Laboratories) at 4
 
8
 
C in PBS/
0.2% Tween 20/2% nonfat dry milk. Filters were washed in
PBS/0.2% Tween 20/2% nonfat dry milk and incubated with ei-
ther donkey anti–rabbit or anti–mouse secondary antibody (1:2,000
dilution) conjugated to horseradish peroxidase (Amersham Phar-
macia Biotech). Visualization of the immunocomplex was per-
formed using Enhanced Chemiluminescence Plus kit (Amersham
Pharmacia Biotech).
 
Cell Death ELISA.
 
DNA fragmentation was detected using
Cell Death ELISA Plus kit (Roche Biochemical) as recommended
by the manufacturer. Mono- and oligonucleosomal DNA were
detected in the cytoplasmic fraction of cell lysates. In brief, cell
lysates were incubated in antihistone-coated microtiter plates.
DNA attached to the bound histones was detected with peroxi-
dase-conjugated anti-DNA antibody. After wash steps, substrate
was added to the microtiter wells and color change was read at
405 nm by a microplate reader (Bio-Tek Instruments).
 
Results
 
Spontaneous Apoptosis Occurs in Monocytes, But Not Macro-
phages.
 
Previous investigators demonstrated decreasing
cell numbers over the first 3 d when monocytes were cul-
tured in serum (32, 42–44). Here, we examined the occur-
rence of apoptosis during monocyte to macrophage differ-
entiation in serum. TUNEL analysis, which measures DNA
fragmentation, demonstrated peak apoptosis at 1 and 2 d af-
ter isolation, though few or no TUNEL-positive macro-
phages were observed at 0, 3, 7, and 14 d (Fig. 1 A). Quan-
titative analyses of subdiploid DNA content in serum-treated
monocytes (Fig. 1, B and C) revealed enhanced spontane-
ous apoptosis in the 0.5-, 1-, and 2-d cultures (12.1 
 
6
 
 1.7,
26 
 
6
 
 4.7, and 23 
 
6
 
 9.0%, respectively). However, macro-
phages at 3, 7, and 14 d (Fig. 1, B and C) displayed mini-
mal hypodiploid DNA content (
 
,
 
6%). To corroborate the
quantification of apoptosis as determined by subdiploid
DNA content, flow cytometry measuring FITC-dUTP in-
corporation (TUNEL) was performed. Since maximal apop-
tosis was exhibited in 1-d monocyte cultures, immediately
isolated (day 0) and 1-d monocytes were examined. In the
1-d monocyte cultures, 25.8 
 
6
 
 2% TUNEL-positive cells
were detected (Fig. 1 D), similar to the analysis of subdip-
loid DNA (Fig. 1 B). Little or no TUNEL positivity (
 
,
 
1%)
was observed in monocytes immediately after isolation.
Furthermore, cell counting by trypan blue exclusion re-
vealed a 50–60% reduction of monocyte cell numbers at 3 d
after isolation (not shown), indicating that the apoptosis
observed at 1 and 2 d resulted in the cumulative loss of
cells. Consistent with previous reports (5, 30–32), 
 
.
 
70% of
serum-deprived monocytes underwent spontaneous apop-
tosis after 24 h (not shown). Collectively, these data dem-
onstrate that in vitro–differentiated macrophages, unlike
monocytes, undergo little or no spontaneous apoptosis.
 
Inhibition of Fas–FasL Interaction Rescues Monocytes from
Spontaneous Apoptosis.
 
Monocytes cultured in serum undergo 
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spontaneous apoptosis that may be mediated by the Fas–
FasL pathway. Flow cytometric analyses of surface Fas and
FasL revealed that Fas was present on essentially all the cells,
although it was more strongly expressed on monocytes
compared with macrophages (Fig. 2 A). FasL was also de-
tected on the surface of both monocytes and macrophages,
though more FasL was expressed on macrophages (Fig. 2 A).
To confirm that the detection of Fas and FasL was specific,
flow cytometric analysis using FITC-conjugated anti-CD3
and anti–TCR-
 
g
 
/
 
d
 
 antibodies demonstrated comparable
staining to the isotype control in both monocytes and mac-
rophages (Fig. 2 A). To define the mechanism(s) responsi-
ble for monocyte apoptosis, inhibitory FasL antibodies and
the general caspase inhibitor zVAD.fmk were compared
with TNF-
 
a
 
, which was previously shown to inhibit mono-
cyte apoptosis (2, 5, 30, 31). Addition of either C-20 (82%
inhibition) or 4H9 (41% inhibition, not shown) neutraliz-
ing anti-FasL antibodies to isolated monocytes in 20% se-
rum significantly (
 
P
 
 , 
 
0.02) inhibited spontaneous apopto-
sis compared with IgG-treated or medium control–treated
(mock) monocytes (Fig. 2 B). Similarly, TNF-
 
a
 
 inhibited
apoptosis by 62% (
 
P
 
 , 
 
0.02) while the general caspase in-
hibitor zVAD.fmk partially blocked spontaneous apoptosis
(41%,
 
 P 
 
, 
 
0.01) in 1-d (Fig. 2 B) and 2-d (not shown) mono-
cyte cultures. The contribution of caspase activation to Fas-
mediated apoptosis in monocytes was further examined by
immunoblot analyses. Reduced detection of the pro-
caspases 8 and 3 was observed in extracts from 0 and 1-d
monocytes (Fig. 2 C) compared with 7-d macrophages. The
intermediate active form of caspase 3 (p24 [45]) was de-
tected in extracts of monocytes on days 0 and 1, but not
those from day 7 macrophages. As a control, Fas-agonistic
antibody–treated Jurkat T cells also displayed the interme-
diate active caspase 3 (not shown). These data indicate that
Figure 1. Peripheral blood monocytes, but not macrophages, undergo spontaneous apoptosis. (A) Representative photomicrographs of TUNEL-posi-
tive monocytes. Day 0 monocytes represent cells obtained within 2 h of isolation. Arrows identify cells that are positive for both Hoechst (top panels) and
TUNEL (bottom panels) on days 1, 2, and 3. Original magnification of the digital photomicrographs: 8003. (B) Representative histogram of DNA con-
tent in monocytes and macrophages. Triplicate cultures were harvested at 0, 1, 2, 3, 7, and 14 d, fixed, and analyzed by flow cytometry after PI staining.
Histograms were formed in the linear scale to identify subdiploid DNA (,2N), characteristic of apoptosis. (C) Monocytes exhibit hypodiploid DNA
content. Triplicate cultures were harvested as described above. Values represent the mean 6 SE of five independent determinations, which were com-
pared for statistical significance by unpaired two-tailed Student’s t test. *P , 0.02 relative to day 0. (D) Representative histogram of FITC positivity in 0
and 1-d monocytes. Monocytes obtained immediately after isolation or 1 d later were fixed in 1% paraformaldehyde, permeabilized in 70% ETOH, and
stained for TUNEL using FITC-labeled dUTP as described in Materials and Methods. TUNEL positivity was quantified by flow cytometry that mea-
sured FITC-labeled dUTP incorporation (x-axis) and cell number (y-axis). 
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the spontaneous monocyte apoptosis that occurs in serum
was attributed to Fas–FasL interaction and caspase activation.
 
Macrophage Resistance to Fas-induced Cell Death Is Associated
with Flip Upregulation.
 
The ability of agonistic Fas antibody
and TNF-
 
a
 
 to induce apoptosis in macrophages was exam-
ined. Macrophages were resistant to spontaneous and ago-
nistic Fas antibody–induced apoptosis (Fig. 3 A) as indicated
by normal DNA content and mitochondrial membrane in-
tegrity, suggesting that a potent inhibitor of the death re-
ceptor–mediated pathway, not present in monocytes, may
be upregulated in macrophages. As a control, agonistic Fas
antibody induced apoptosis in Jurkat T cells and U937 cells
(not shown). In certain cell types, Flip overexpression has
been shown to directly inhibit Fas-mediated apoptosis (29),
indicating that Flip may function to promote survival during
monocyte to macrophage differentiation. Previous investiga-
tions demonstrated that by day 3 in culture, monocytes be-
gin to differentiate into macrophages based on morphology,
cell surface markers including vitronectin (CD51 [32]), trans-
ferrin receptor (CD71; not shown), and cytolytic activity
(46).
 
 
 
Immunoblot analyses performed on isolated periph-
eral blood monocytes harvested at 0, 1, 2, 3, 7, and 14 d re-
vealed that Flip upregulation was associated with macro-
phage differentiation and reduced apoptosis, beginning on
day 3 (Fig. 3 B).
 
 
 
Flip
 
L
 
 was detected at 7 and 14 d of mac-
rophage differentiation, whereas Flip
 
S
 
 was highly expressed
3 d after isolation (Fig. 3 B). The ratio of Flip
 
L to FlipS on
days 3, 7, and 14 varied between individuals. Although low
levels of Flip were detected before day 3 in some individu-
als, Flip upregulation at 3, 7, and 14 d was observed in ev-
ery individual examined (n 5 10). These data demonstrate
that the decreased spontaneous apoptosis seen during and
after macrophage differentiation is associated with Flip up-
regulation.
To determine if the Flip expression observed at 3 d is tran-
scriptionally regulated, RT-PCR analyses performed with
specific primers that differentiate between the two Flip iso-
forms revealed minimal FlipS or FlipL mRNA transcripts in
immediately isolated monocytes (Day 0). However, FlipS and
FlipL mRNA were upregulated on day 3 (Fig. 3 C). Equally
expressed b-actin mRNA transcripts indicated that similar
levels of mRNA were amplified in all samples. These data
demonstrate that Flip is upregulated at the transcriptional
level during monocyte differentiation into macrophages.
Figure 2. Spontaneous monocyte apopto-
sis is regulated by Fas–FasL. (A) Monocytes
and macrophages express surface Fas and
FasL. Cultures were blocked in human se-
rum, stained with FITC-labeled anti-Fas,
anti-CD3, anti–TCR-g/d, or isotype con-
trol. Additional cells were stained with anti-
FasL (C-20), anti-FasL (4H9), or normal
rabbit IgG, then with FITC-labeled goat
anti–rabbit or rabbit anti–hamster antibody.
All cultures were then analyzed by flow cy-
tometry. Control Igs are in blue; the experi-
mental antibodies (anti-Fas, anti-FasL, anti–
TCR-g/d, or anti-CD3) are in red. (B)
Neutralizing anti-FasL antibody protects
monocytes cultured in serum from sponta-
neous apoptosis. Immediately after isolation,
triplicate cultures of monocytes were treated
with neutralizing anti-FasL (10 mg/ml), con-
trol IgG (10 mg/ml), zVAD.fmk (20 mM),
TNF-a (10 ng/ml), or control medium
(Mock) for 24 h. Cultures were fixed in 70%
ETOH, incubated in PI (50 mg/ml), and an-
alyzed by flow cytometry. Values represent
the mean 6 SE of three independent exper-
iments. Anti-FasL and control IgG–treated
cultures, and zVAD.fmk-, TNF-a–, and
mock-treated cultures were compared for
statistical significance by unpaired two-tailed
Student’s t test. *P , 0.0001 for anti-FasL,
P , 0.01 for zVAD.fmk, and P , 0.02 for
TNF-a. (C) Whole cell extracts (25 mg)
were prepared from peripheral blood mono-
cytes and macrophages which had been cul-
tured in 20% FBS/RPMI/1 mg/ml poly-
myxin B, and isolated at 0, 1, 2, and 7 d.
Extracts were subjected to SDS-PAGE on
12.5% polyacrylamide gels. Gels were trans-
ferred to Immobilon P for immunoblot
analysis with anti-caspases 8 and 3 antibod-
ies. The anti-caspase 8 and 3 immunoblots
are representative of three individuals.1684 Flip Protects Macrophages from Fas-mediated Apoptosis
Flip Overexpression Protects Monocytic Cells from Fas-mediated
Apoptosis. Monocytes do not express Flip and are suscep-
tible to Fas-mediated apoptosis, suggesting that forced ex-
pression of Flip may protect monocytes from apoptosis in
response to Fas ligation. Since peripheral blood monocytes
are difficult to transfect, the monocytic cell line U937, which
expresses little or no Flip (not shown) (47) and undergoes
apoptosis in response to agonistic Fas antibody (6), was
used. An established cell death assay (48–50) was performed
using expression plasmids encoding FlipL, FlipS (24), Bcl-2
(35), or empty vector transfected in combination with an
EGFP expression plasmid. Flow cytometric analyses were
used to determine changes in cell viability as indicated by
the number of EGFP-positive cells. Equal levels of FlipS
and FlipL expression were demonstrated by transient trans-
fection of the expression plasmids in 293 cells (not shown).
Expression vectors encoding FlipL or FlipS protected U937-
transfected cells from Fas-mediated apoptosis in a dose-
dependent manner (Fig. 4). In addition, FlipS-transfected
U937 cells displayed increased viability compared with FlipL-
transfected cells (15-fold vs. 8-fold). On the contrary, Bcl-2
provided little protection (twofold) compared with empty
vector–transfected U937 cells (Fig. 4).
Acute Flip Inhibition Induces Macrophage Apoptosis. To de-
termine if Flip is functionally significant for macrophage
survival, FITC-conjugated antisense oligonucleotides were
created complementary to a sequence that included the
start site of the Flip open reading frame (24). Flow cytome-
try revealed similar uptake (Fig. 5 A) of the antisense and
control nonsense oligonucleotides (39) in day 7 macrophages.
Immunoblot analyses of oligonucleotide-treated macro-
phages demonstrated decreased expression of both Flip iso-
forms, using both 10 and 20 mM of the antisense oligonu-
cleotides, compared with medium control (mock) or control
oligonucleotide-treated macrophages (Fig. 5 B). Flow cyto-
metric analyses revealed that 40 6 3% of the antisense oli-
gonucleotide–treated macrophages underwent apoptosis (Fig.
5 C) compared with 1 6 0.1 and 3 6 0.5% of mock- and
control oligonucleotide–treated macrophages, respectively.
Furthermore, reduction of the procaspase 3 (Fig. 5 B) was
observed in the antisense oligonucleotide–treated macro-
phages compared with mock or control oligonucleotide–
treated cells, supporting the role of caspase activation in
macrophage cell death. Inhibition of Fas–FasL interactions
by two different antagonistic FasL antibodies (40% with
C-20 and 67% with 4H9) suppressed macrophage apoptosis
Figure 3. Macrophage resistance to Fas-mediated apoptosis is associ-
ated with Flip expression. (A) Macrophages are resistant to Fas-induced
apoptosis. Triplicate cultures of macrophages differentiated for 7 d in 20%
FBS/polymixin B were treated with activating anti-Fas mAb (250 ng/ml),
control Ig, or TNF-a (10 ng/ml) for 1 d, fixed in 70% ETOH, and incu-
bated in PI (50 mg/ml) for flow cytometry analysis to determine hypodip-
loid DNA content. Parallel cultures were incubated with Rh123 (0.1 mg/ml)
for 30 min before analysis by flow cytometry. The results represent a
mean of three experiments. (B) Flip is upregulated in macrophages.
Whole cell extracts (25 mg) were prepared from peripheral blood mono-
cytes and macrophages cultured in 20% FBS/RPMI/1 mg/ml polymyxin
B and isolated at the indicated times. Extracts were subjected to SDS-
PAGE on 12.5% polyacrylamide gels. Gels were transferred to Immo-
bilon P for immunoblot analysis with anti-Flip. The anti-Flip immuno-
blot is a representative of 10 individuals. (C) Flip transcript levels are
upregulated during monocyte to macrophage differentiation. RT-PCR
analysis was performed on total RNA, and the 1,470-bp FlipL, 620-bp
FlipS, and 838-bp b-actin amplified fragments were fractionated on 1.0%
agarose gel and visualized by ethidium bromide staining.
Figure 4. Flip overexpression rescues GFP-positive U937 cultures from
Fas-mediated cell death. U937 cultures were transfected with 2 mg of the
CMV-EGFP–expressing plasmid and either expression vectors 4, 6, or 8 mg
of CMV-FlipL or CMV-FlipS using FuGENE™. Empty CMV vector was
added to transfections to yield a total of 10 mg of DNA per transfection. Af-
ter transfection, cultures were incubated in 20% FBS/RPMI for 12 h and
treated with agonistic anti-Fas antibody (500 ng/ml) for an additional 12 h.
U937 cells were collected, and EGFP-expressing cells were quantified by
flow cytometry. Nonviable cells were excluded by PI incorporation. Before
addition of Fas agonistic antibody, z6,000 GFP-positive cells were ob-
served. The data are representative of two independent experiments.1685 Perlman et al.
induced by Flip antisense treatment, as indicated by trypan
blue exclusion (not shown) and by DNA fragmentation
(Fig. 5 D). Addition of FasL antibodies or control IgG had
no effect on the viability of control oligonucleotide–treated
cultures (not shown). These data demonstrate that Flip
contributes to macrophage survival and document for the
first time the functional significance of endogenous Flip ex-
pression, which is necessary for survival during in vitro
monocyte to macrophage differentiation.
Discussion
Isolated monocytes are highly sensitive to apoptosis in-
duced by Fas–FasL ligation, whereas differentiated macro-
phages are resistant. Our data document that Fas–FasL in-
teractions, which mediate caspase activation, contribute to
the continued reduction of monocytes during the first 48–
72 h. As early as 2 h after isolation (day 0), before the ap-
pearance of hypodiploid DNA or TUNEL positivity, caspases
were already activated. This could be the result of activa-
tion of caspases, where the inactive procaspase has been
cleaved to form the active protease (51). It is also possible
that the increased procaspases detected in day 7 macro-
phages may be attributed to increased synthesis. While our
data do not exclude this possibility, a previous study dem-
onstrated caspase 8 activity in freshly isolated monocytes
(52), suggesting that the reductions seen in our study (days
0 and 1) were at least in part due to caspase activation. We
also observed the intermediate cleaved caspase 3 (p24) isoform
on days 0 and 1, but not day 7, indicating that activation
had occurred at the early time points. Protection of mono-
cytes from apoptosis by the caspase inhibitor zVAD.fmk
further supports the interpretation that caspases were acti-
vated immediately after isolation (,2 h; Fig. 2 B). The fact
Figure 5. Acute inhibition of Flip in macrophages promotes apoptosis. (A) Flow cytometry demonstrates equal uptake of control nonsense (black, NS-
Flip) and antisense (red, AS-Flip) oligonucleotides. Monocytes isolated by countercurrent centrifugal elutriation were differentiated in 20% FBS/RPMI/1
mg/ml polymyxin B for 7 d. FITC-conjugated oligonucleotides (10 and 20 mM) were added for 24 h. Cultures were then harvested, fixed in 70%
ETOH, and analyzed by flow cytometry. (B) Flip antisense oligonucleotides reduced Flip expression associated with caspase 3 activation. Parallel cultures, as
described above, treated with nonsense (NS) or antisense (AS) FITC-conjugated oligonucleotides were analyzed for Flip expression and caspase 3 expres-
sion. Whole cell extracts (50 mg) were subjected to SDS-PAGE on 12.5% polyacrylamide gels and transferred to Immobilon P for immunoblot analysis
with anti-Flip, anti–caspase 8, and antitubulin antibodies. (C) Inhibition of Flip induces apoptosis in macrophages. Parallel cultures, as described above,
were performed in triplicate and analyzed for hypodiploid DNA by flow cytometry. The results in this figure are representative of two experiments. Val-
ues represent the mean 6 SE of triplicate determinations. (D) Neutralization of FasL blocks Flip antisense–induced macrophage cell death. 7 d–differentiated
macrophages were incubated with anti-FasL (10 mg/ml, C-20 or 4H9) or control IgG for 1 h followed by the addition of the nonsense (NS) or antisense
(AS) oligonucleotides (20 mM) for 24 h. DNA fragmentation was analyzed using the Cell Death ELISA Plus kit, which detects mono- and oligonucleo-
somal DNA fragments. Values represent the mean 6 SE of triplicate determinations of a representative experiment.1686 Flip Protects Macrophages from Fas-mediated Apoptosis
that caspase activation appears to be initiated even during
isolation may explain the lack of complete inhibition by
neutralizing anti-FasL or zVAD.fmk.
A decline in monocyte cell number by day 3 correlated
with Flip expression. Both RT-PCR and immunoblot
analyses demonstrated an upregulation in Flip expression
by day 3. Although the ratios of the two isoforms, as deter-
mined by immunoblot analyses, varied between individuals
at 3, 7, and 14 d, our data suggest that Flip expression was
responsible for the protection against apoptosis observed on
day 3 and thereafter. The incubation of macrophages with
Flip antisense oligonucleotides reduced Flip expression by
Western blot analyses and increased apoptosis as determined
by hypodiploid DNA content. Furthermore, the concur-
rent reduction of procaspase 3 in the Flip antisense oligo-
nucleotide–treated macrophages suggests that this process
activated caspases. Additionally, the marked protection of
U937 cells from Fas-mediated apoptosis by Flip, but not
Bcl-2, supports the importance of Flip for macrophage sur-
vival. Recently, stably expressed Bcl-2 was shown to pro-
vide modest protection against Fas-mediated apoptosis in
U937 cells (53), which was comparable to that observed in
our study. Decreased numbers of GFP-positive U937 cells
were not seen even when higher concentrations of the Flip
expression plasmids were used. However, in other cell types,
overexpression of Flip (22, 24, 25, 27; and data not shown)
resulted in cell death, suggesting that the effects of Flip
overexpression may be cell type specific. These data docu-
ment an important role for Flip in the resistance of mac-
rophages to Fas–FasL-mediated cell death.
Surface Fas was expressed on essentially all day 7 macro-
phages, though less intensely compared with monocytes,
suggesting that reduction in the amount of surface Fas on
macrophages may have contributed to reduced apoptosis.
However, in a recent investigation primary endothelial
cells, which express low levels of Fas (54, 55) comparable
to those observed on macrophages, were sensitized to Fas-
induced apoptosis by oxidized lipids (55). Interestingly, the
susceptibility of endothelial cells to Fas-mediated apoptosis
induced by oxidized lipids correlated with Flip downregu-
lation (41) even though the level of surface Fas remained
unchanged. Fas–FasL interactions also mediated apoptosis
in macrophages after Flip inhibition, since neutralization of
FasL suppressed macrophage apoptosis in the presence of
the Flip antisense oligonucleotides. These data demonstrate
that Flip, and not reduced surface Fas, was responsible for
the absence of Fas-mediated macrophage apoptosis.
Activation of macrophages is an integral component of
several host defense mechanisms, including activation of T
cells, release of inflammatory cytokines, removal of virus-
infected cells, and the antibody-dependent and -indepen-
dent killing of tumorigenic cells (56). Although macrophages
are resistant to Fas-mediated apoptosis, they may be ren-
dered Fas sensitive. TNF-a or a combination of TNF-a
plus INF-g sensitized mouse peritoneal  macrophages to
Fas-mediated apoptosis in vitro. Additionally, Th1 CD41
T cells induced apoptosis of antigen-pulsed, IFN-g–treated
peritoneal macrophages, which was mediated by Fas–FasL
interactions (57). Studies have yet to determine if decreased
Flip expression contributed to macrophage apoptosis under
these conditions. FasL on macrophages may not induce ap-
optosis of T cells for which they serve as the APCs, because
unactivated T cells strongly express Flip (24, 58, 59). How-
ever, after stimulation, T cells downregulate Flip expression
and undergo suicide, resulting in activation-induced cell
death that is mediated by the Fas–FasL pathway (24, 58–
61). Thus, depending on the environmental milieu, T cell
and macrophage sensitivity to Fas-mediated apoptosis ap-
pears to be regulated by Flip expression.
Circulating blood monocytes extravasate into tissues and
differentiate into macrophages. Persistent expression of FasL
by adenoviral delivery to endothelial cells prevented mono-
cytes from emigrating into the inflamed tissue (54), sug-
gesting that Fas is functional on monocyte surfaces in vivo.
In addition, mice carrying functional mutations of Fas–FasL
displayed elevated macrophage cell numbers (11), indicat-
ing the importance of Fas–FasL in regulating monocyte/
macrophage homeostasis. Recently, we identified Flip ex-
pression in macrophages isolated from synovial fluid and in
the synovial tissues (not shown) of patients with rheuma-
toid arthritis, demonstrating a potential significance for Flip
expression in vivo. Additionally, animals with experimental
arthritis also displayed increased numbers of synovial mac-
rophages that were Flip positive (not shown). Thus, modu-
lation of Flip expression may provide a novel therapeutic
approach to diseases mediated by macrophages, such as
rheumatoid arthritis or atherosclerosis.
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